Insider sales disclosed
Alistair N. Sporck, who serves as vice president of the Contactor Business Unit at AEHR TEST SYSTEMS (NASDAQ:AEHR), sold 2,000 shares of the company's common stock on April 10, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a per-share price of $67.365, producing proceeds of $134,730.
The filing also shows that Sporck disposed of an additional 220 shares on April 11, 2026, at $70.43 per share. That second transaction, identified in the filing as covering tax obligations, totaled $15,494.
Post-transaction holdings
After these transactions, Sporck is reported to directly hold 22,635 shares of AEHR Test Systems common stock. That direct holding figure includes shares that remain subject to unvested restricted stock units. In addition to direct ownership, Sporck is listed as indirectly owning 7,177 shares through a trust.
Market context and valuation note
The insider sales occurred while AEHR shares trade near a 52-week high of $74.53, following a reported one-year return of 763%. An InvestingPro analysis cited in the filing commentary characterizes the stock as appearing overvalued at current levels.
Recent financial results
In other company disclosures, Aehr Test Systems reported mixed financial results for the third quarter of fiscal 2026. The company posted earnings per share of -$0.05, which was ahead of the analyst consensus of -$0.07. Revenue for the quarter was $10.3 million, marginally below the consensus estimate of $10.8 million.
Despite the revenue shortfall, the company reported record quarterly bookings of $37.2 million, and a backlog that the company says exceeds $50 million. Those booking metrics have prompted several analysts to lift price targets: Freedom Broker raised its target to $61 while keeping a Hold rating, and Lake Street increased its target to $56 while maintaining a Buy rating. Analysts cited the bookings strength in explaining their revised targets, and their guidance adjustments reflect a positive view even as revenue lagged estimates.
What is clear
The filings provide a transparent record of Sporck's April dispositions and a snapshot of AEHR's most recent quarter - a mix of upside in EPS and bookings, and a slight revenue miss. The company remains positioned with a sizeable backlog and has drawn valuation scrutiny from market commentators.